PF-04620110,
PF-04620110,
1109276-89-2,
CHEMBL1835919,
2-(trans-4-(4-(4-Amino-5-oxo-7,8-dihydropyrimido[5,4-f][1,4]oxazepin-6(5H)-yl)phenyl)cyclohexyl)acetic acid,
PF-4620110,
2-(trans-4-(4-(4-Amino-5-oxo-7,8-dihydropyrimido[5,4-f]-[1,4]oxazepin-6(5H)-yl)phenyl)cyclohexyl)acetic acid,
trans-4-[4-(4-Amino-7,8-dihydro-5-oxopyrimido[5,4-f][1,4]oxazepin-6(5H)-yl)phenyl]cyclohexaneacetic acid,
UNII-CQ4M18RLJW,
CQ4M18RLJW,
GTPL7829,
SCHEMBL1424359,
SCHEMBL1424362,
SCHEMBL1425038,
SCHEMBL13954265,
DTXSID90677361,
GEVVQZHMFVFGLN-HDJSIYSDSA-N,
HMS3653O15,
BCP16812,
2009AA,
BDBM50355142,
s7192,
AKOS016011621,
ZINC100067711,
ZINC116139756,
CS-0370,
SB19585,
KS-00001D39,
NCGC00389511-01,
4CA-0991,
HY-13009,
AJ-117080,
AX8245855,
FT-0701171,
PF04620110,
SW220213-1,
W-5810,
PF-04620110, >=98% (HPLC),
{4-[4-(4-Amino-5-oxo-7,8-dihydropyrimido[5,4-f][1,4]oxazepin-6(5H)-yl)phenyl]cyclohexyl}acetic acid,
{Trans-4-[4-(4-amino-5-oxo-7,8-dihydropyrimido[5,4-f][1,4]oxazepin-6(5H)-yl)phenyl]cyclohexyl} Acetic Acid,
{Trans-4-[4-(4-amino-5-oxo-7,8-dihydropyrimido[5,4-f][1,4]oxazepin-6(5H)-yl)phenyl]cyclohexyl}acetic acid,
2-[(1r,4r)-4-(4-{4-amino-5-oxo-5H,6H,7H,8H-pyrimido[5,4-f][1,4]oxazepin-6-yl}phenyl)cyclohexyl]acetic acid,
cyclohexaneacetic acid, 4-[4-(4-amino-7,8-dihydro-5-oxopyrimido[5,4-f][1,4]oxazepin-6(5H)-yl)phenyl]-, trans-,
trans-4-[4-(4-Amino-7,8-dihydro-5-oxopyrimido[5,4-f][1,4]oxazepin-6(5H)-yl)phenyl]cyclohexaneacetic,
D0M0NT,
GEVVQZHMFVFGLN-UHFFFAOYSA-N,
C21H24N4O4,
PF 04620110,
A4384,
A11526,